Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 October 2021
EMA’s human medicines committee (CHMP) recommended two oncology medicines for approval at its October 2021 meeting. To read meeting highlights from CHMP (11-14 October 2021), click here:...
EORTC FREE WEBINAR: “CLINICAL TRIALS: THE PATIENT IN ACADEMIC STUDIES”
EORTC is organizing a free one-hour webinar for the lay audience which will be held on the 15th September, 2021 from 1:30-2.30 pm CEST. The topic will be “Clinical trials – The patient in academic studies” and the challenges patients face in this regard: where to find...
AAADV-CDDF Satellite Session on Global Pediatric Neuro-Oncology Network
The AAADV and the CDDF hold a joint satellite session on Global Pediatric Neuro-Oncology Network at the 2021 AAADV workshop on 29 September 2021. Stay informed about the workshop and join the stimulating discussion with renowned experts in oncology drug development....
Joint Letter on COVID-19 and Cancer
The Cancer Drug Development Forum fully supports the European Cancer Patient Coalition's initiative, Joint Letter on COVID-19 and Cancer, and calls for the action to identify the impact of the pandemic on cancer services and design services to mitigate this. CLICK...
CDDF 12th Spring Conference meeting report is now available!
The CDDF 12th Spring Conference took place on 8-10 February 2021, virtually. This multi-stakeholder, interactive meeting offered plenary lectures with moderated discussions, including case studies as well as networking opportunities. The programme focused on the...
NEW CDDF INDUSTRY PARTNER – Varian Medical Systems
Varian Medical Systems becomes first medical technology company to join The Cancer Drug Development Forum (CDDF). We welcome Varian to the CDDF Industry Partners Platform and look forward to great collaboration in 2021! To read...
HAPPY HOLIDAY SEASON!
Unlocking the Value of Personalised Cancer Care
Access to Personalised Oncology in Europe, a new report by LSE consulting commissioned by EFPIA, identifies the barriers to better deployment of personalised cancer treatment for European cancer patients and makes concrete recommendations on how to advance and...
Virtual Meeting: Together against Cancer: How can Europe benefit from breakthroughs in personalised oncology?
A virtual meeting, "How can Europe benefit from breakthroughs in personalised oncology?" is organized by the European Federation of Pharmaceutical Industries and Associations, the London School of Economics (LSE), the European Cancer Patient Coalition (ECPC), and the...